IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Lancet Diabetes and Endocrinology,The

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

10.82

h-Index

2024-2025

 189

Rank

2024-2025

 53

SJR

2024-2025

 12.19

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Lancet Diabetes and Endocrinology,The
Abbreviation Lancet Diabetes Endocrinol.
Publication Type Journal
Subject Area, Categories, Scope Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Internal Medicine (Q1)
h-index 189
Overall Rank/Ranking 53
SCImago Journal Rank (SJR) 12.19
Impact Score 10.82
Publisher Elsevier Ltd
Country United Kingdom
ISSN 22138595, 22138587
Best Quartile Q1
Coverage History 2013-2025




About Lancet Diabetes and Endocrinology,The


Lancet Diabetes and Endocrinology,The is a journal covering the technologies/fields/categories related to Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Internal Medicine (Q1). It is published by Elsevier Ltd. The overall rank of Lancet Diabetes and Endocrinology,The is 53. According to SCImago Journal Rank (SJR), this journal is ranked 12.19. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 189. The best quartile for this journal is Q1.

The ISSN of Lancet Diabetes and Endocrinology,The journal is 22138595, 22138587. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Lancet Diabetes and Endocrinology,The is cited by a total of 6796 articles during the last 3 years (Preceding 2024).


Lancet Diabetes and Endocrinology,The Impact IF 2024-2025


The Impact IF 2024 of Lancet Diabetes and Endocrinology,The is 10.82, which is computed in 2025 as per its definition. Lancet Diabetes and Endocrinology,The IF is decreased by a factor of 1.66 and approximate percentage change is -13.3% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Lancet Diabetes and Endocrinology,The Impact IF 2025 Prediction


Impact IF 2024 of Lancet Diabetes and Endocrinology,The is 10.82. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of Lancet Diabetes and Endocrinology,The. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 10.82
2023 12.48
2022 12.79
2021 11.20
2020 8.18
2019 8.13
2018 6.79
2017 5.54
2016 6.40
2015 5.70
2014 2.53

Lancet Diabetes and Endocrinology,The h-index


  Table Setting

Lancet Diabetes and Endocrinology,The has an h-index of 189. It means 189 articles of this journal have more than 189 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Lancet Diabetes and Endocrinology,The ISSN


The ISSN of Lancet Diabetes and Endocrinology,The is 22138595, 22138587. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Lancet Diabetes and Endocrinology,The Rank and SCImago Journal Rank (SJR)


The overall rank of Lancet Diabetes and Endocrinology,The is 53. According to SCImago Journal Rank (SJR), this journal is ranked 12.19. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Lancet Diabetes and Endocrinology,The by Year


Year SJR
2025/2026 Coming Soon
2024 12.19
2023 10.247
2022 8.217
2021 9.767
2020 8.596
2019 9.337
2018 10.088
2017 9.705
2016 8.958
2015 7.295
2014 2.791

Ranking of Lancet Diabetes and Endocrinology,The by Year


Year Ranking
2025/2026 Coming Soon
2024 53
2023 74
2022 108
2021 69
2020 106
2019 82
2018 77
2017 83
2016 99
2015 141
2014 765

Lancet Diabetes and Endocrinology,The Publisher


Table Setting

Lancet Diabetes and Endocrinology,The is published by Elsevier Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2013-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Lancet Diabetes and Endocrinology,The is Lancet Diabetes Endocrinol.. This abbreviation ('Lancet Diabetes Endocrinol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Lancet Diabetes and Endocrinology,The


If your research field is/are related to Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Internal Medicine (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Lancet Diabetes and Endocrinology,The?

Lancet Diabetes and Endocrinology,The latest impact IF is 10.82. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 12.79 (2022) and 2.53 (2014), respectively, in the last 11 years. Moreover, its average IS is 8.23 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Lancet Diabetes and Endocrinology,The?

The Lancet Diabetes and Endocrinology,The has an SJR (SCImago Journal Rank) of 12.19, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 12.19 in 2024 and the lowest being 2.791 in 2014. Furthermore, the average SJR of the Lancet Diabetes and Endocrinology,The over the previous 11-year period stands at 8.23.


What's the latest h-index of the Lancet Diabetes and Endocrinology,The?

The latest h-index of the Lancet Diabetes and Endocrinology,The is 189.


Who's the publisher of the Lancet Diabetes and Endocrinology,The?

The Lancet Diabetes and Endocrinology,The is published by the Elsevier Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the Lancet Diabetes and Endocrinology,The?

The Lancet Diabetes and Endocrinology,The is currently ranked 53 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 53 in 2024 and its lowest position of 765 in 2014.


What's the abbreviation or short name for the Lancet Diabetes and Endocrinology,The?

The standard ISO4 abbreviation for the Lancet Diabetes and Endocrinology,The is Lancet Diabetes Endocrinol..


Is the "Lancet Diabetes and Endocrinology,The" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Lancet Diabetes and Endocrinology,The is classified as a journal that the Elsevier Ltd publishes.


What's the scope or major areas of the Lancet Diabetes and Endocrinology,The?

The Lancet Diabetes and Endocrinology,The encompasses the following areas:

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Lancet Diabetes and Endocrinology,The?

The Lancet Diabetes and Endocrinology,The is assigned the following International Standard Serial Numbers (ISSN): 22138595, 22138587.


What's the best quartile of the Lancet Diabetes and Endocrinology,The?

The best quartile for the Lancet Diabetes and Endocrinology,The is Q1 (2024).


What's the coverage history of the Lancet Diabetes and Endocrinology,The?

The Lancet Diabetes and Endocrinology,The coverage history can be summarized as follows: 2013-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Applied Ecology and Environmental Research journal 19122 Corvinus University of Budapest 48 0.84
Journal of Geriatric Physical Therapy journal 8686 Lippincott Williams and Wilkins Ltd. 53 1.55
Materials Research journal 15597 Universidade Federal de Sao Carlos 75 1.40
Journal of Classical Sociology journal 16960 SAGE Publications Ltd 31 0.68
Abacus journal 11890 Wiley-Blackwell Publishing Ltd 56 2.95
British Journal of Special Education journal 14055 Wiley-Blackwell Publishing Ltd 45 1.43
Population Review journal 19550 Sociological Demography Press 15 0.59
Biological Procedures Online journal 5232 BioMed Central Ltd 51 4.00
Journal of Immigrant and Refugee Studies journal 7357 Routledge 39 2.17
Proteomics - Clinical Applications journal 8540 Wiley-VCH Verlag 67 2.59

Check complete list




Year wise Impact Score (IS) of Lancet Diabetes and Endocrinology,The

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 10.82
2023 12.48
2022 12.79
2021 11.20
2020 8.18
2019 8.13
2018 6.79
2017 5.54
2016 6.40
2015 5.70
2014 2.53



Top Journals/Conferences in Endocrinology

Endocrine Reviews
The Endocrine Society | United States

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Bone Research
Nature Publishing Group | United Kingdom

Endocrine Pathology
Springer | United States

Diabetologia
Springer Science and Business Media Deutschland GmbH | Germany

Diabetes Technology and Therapeutics
Mary Ann Liebert Inc. | United States

Metabolism: Clinical and Experimental
W.B. Saunders | United States

Trends in Endocrinology and Metabolism
Elsevier Inc. | United States

See All

Top Journals/Conferences in Endocrinology, Diabetes and Metabolism

Endocrine Reviews
The Endocrine Society | United States

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Bone Research
Nature Publishing Group | United Kingdom

Endocrine Pathology
Springer | United States

Diabetologia
Springer Science and Business Media Deutschland GmbH | Germany

Diabetes Technology and Therapeutics
Mary Ann Liebert Inc. | United States

Metabolism: Clinical and Experimental
W.B. Saunders | United States

Trends in Endocrinology and Metabolism
Elsevier Inc. | United States

See All

Top Journals/Conferences in Internal Medicine

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

JAMA Internal Medicine
American Medical Association | United States

Lancet Regional Health - Europe, The
Elsevier Ltd | United Kingdom

Diabetologia
Springer Science and Business Media Deutschland GmbH | Germany

JHEP Reports
Elsevier B.V. | Netherlands

Annals of Internal Medicine
American College of Physicians | United States

Cardiovascular Diabetology
BioMed Central Ltd | United Kingdom

Journal of Internal Medicine
Wiley-Blackwell Publishing Ltd | United Kingdom

Current obesity reports
Springer | United States

See All